Table 4 Prevalence of Pre-treatment drug resistance mutations among enrolled participants, 2008–2010
Variable | HIV DR | 95 % CIs |
|---|---|---|
Sex | ||
Female | 6.7 | 5.2–8.4 |
Male | 5.5 | 3.6–8.1 |
Previous exposure to any form of antiretroviral drugs | ||
Yes | 11.6 | 5.9–19.8 |
No | 5.0 | 4.0–6.2 |
WHO clinical stage | ||
3 or 4 | 6.8 | 5.3–8.6 |
1 or 2 | 6.0 | 3.8–9.0 |
CD4 count (cells/mm 3 ) | ||
<350 | 6.3 | 4.7–8.2 |
≥350 | 6.3 | 4.6–8.2 |
Viral load (copies/ml) | ||
≥1000 | 12.5 | 2.7–32.4 |
<1000 | 6.3 | 5.2–79.1 |